MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 187 filers reported holding MEDICINES CO in Q3 2015. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $18,178,000 | -18.0% | 214,014 | -51.8% | 0.40% | -23.8% |
| Q3 2019 | $22,180,000 | +8.7% | 443,594 | -20.7% | 0.52% | +9.2% |
| Q2 2019 | $20,405,000 | +2.8% | 559,500 | -21.2% | 0.48% | +6.7% |
| Q1 2019 | $19,844,000 | +45.3% | 709,992 | -0.5% | 0.45% | +26.9% |
| Q4 2018 | $13,661,000 | -44.1% | 713,752 | -12.6% | 0.35% | -30.4% |
| Q3 2018 | $24,423,000 | -29.6% | 816,544 | -13.6% | 0.51% | -29.0% |
| Q2 2018 | $34,704,000 | -4.5% | 945,612 | -14.3% | 0.71% | +0.3% |
| Q1 2018 | $36,346,000 | +13.9% | 1,103,387 | -5.5% | 0.71% | +16.2% |
| Q4 2017 | $31,910,000 | -31.7% | 1,167,141 | -7.5% | 0.61% | -28.8% |
| Q3 2017 | $46,714,000 | -3.5% | 1,261,171 | -0.9% | 0.86% | -7.4% |
| Q2 2017 | $48,392,000 | -24.9% | 1,273,136 | -3.4% | 0.93% | -24.5% |
| Q1 2017 | $64,455,000 | +37.8% | 1,318,106 | -4.4% | 1.23% | +30.4% |
| Q4 2016 | $46,779,000 | +30.3% | 1,378,292 | +44.9% | 0.94% | +31.1% |
| Q3 2016 | $35,903,000 | +10.1% | 951,314 | -1.9% | 0.72% | +2.4% |
| Q2 2016 | $32,621,000 | +5.1% | 969,987 | -0.8% | 0.70% | +5.9% |
| Q1 2016 | $31,050,000 | +21.7% | 977,327 | +43.1% | 0.66% | +24.1% |
| Q4 2015 | $25,505,000 | -6.6% | 683,047 | -5.1% | 0.54% | -11.4% |
| Q3 2015 | $27,308,000 | +24.3% | 719,399 | -6.3% | 0.60% | +48.0% |
| Q2 2015 | $21,965,000 | +71.1% | 767,754 | +67.6% | 0.41% | +70.0% |
| Q1 2015 | $12,839,000 | -0.7% | 458,204 | -1.9% | 0.24% | -5.5% |
| Q4 2014 | $12,929,000 | +22.6% | 467,275 | -1.1% | 0.25% | +18.1% |
| Q3 2014 | $10,549,000 | -45.6% | 472,619 | -29.2% | 0.22% | -43.3% |
| Q2 2014 | $19,406,000 | -3.8% | 667,774 | -5.9% | 0.38% | -3.6% |
| Q1 2014 | $20,165,000 | -25.2% | 709,524 | +1.6% | 0.39% | -25.3% |
| Q4 2013 | $26,964,000 | +13.1% | 698,195 | -1.9% | 0.53% | +6.7% |
| Q3 2013 | $23,845,000 | +7.7% | 711,366 | -1.1% | 0.49% | -0.8% |
| Q2 2013 | $22,131,000 | – | 719,472 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |